Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-16T16:12:40.909Z Has data issue: false hasContentIssue false

4 - Iodine–125

Published online by Cambridge University Press:  26 October 2011

Chandrani Liyanage
Affiliation:
Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
Manjula Hettiarachchi
Affiliation:
Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
Get access

Summary

Iodine-125 (125I) has many useful attributes as a general radioisotopic label. It is chemically very reactive and can be incorporated into many types of molecules. It is readily available from several commercial sources with virtually 100% radioisotopic purity, i.e., without any non-radioactive iodine. This means that it is possible to incorporate the maximum number of radioactive atoms into a molecule during the labelling process.

The ease of detection is one of the most useful aspects of radioiodine labels. 125I is detected by placing the sample directly adjacent to a crystal of sodium iodide, containing small amounts of thallium. The gamma rays from the radioisotope are absorbed and the energy is converted to flashes of light. The light photons produced by the crystal are counted by conventional photomultiplier tubes. To increase the efficiency of energy transfer from the isotope to the crystal, a small well is often made in the crystal into which the sample is placed.

The energy from 125I is sufficiently high to give efficient detection but not high enough to cause undue concern with regard to radiation hazards. The literature contains many references to the dangers and hazards of radioisotopic tracers. These references are not only misleading but, in many cases, grossly inaccurate; whilst the handling of mCi amounts of radioiodine during the labelling procedures necessitates care and experience to avoid the hazard of direct ingestion of the volatile radioactive iodine, the use of μCi amounts of label in an assay exposes the laboratory worker to no real hazard.

Type
Chapter
Information
Radionuclides in Biomedical Sciences
An Introduction
, pp. 18 - 32
Publisher: Foundation Books
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Iodine–125
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.006
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Iodine–125
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.006
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Iodine–125
  • Chandrani Liyanage, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka, Manjula Hettiarachchi, Nuclear Medicine Unit, University of Ruhuna, Galle, Sri Lanka
  • Book: Radionuclides in Biomedical Sciences
  • Online publication: 26 October 2011
  • Chapter DOI: https://doi.org/10.1017/UPO9788175968158.006
Available formats
×